Cargando…

Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer

PURPOSE: Precision medicine in pancreatic ductal adenocarcinoma (PDAC) could be substantially supported by tools that allow to establish and monitor the molecular setup of the tumor. In particular, noninvasive approaches are desirable, but not validated. Characterization of circulating tumor DNA (ct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berger, Andreas W., Schwerdel, Daniel, Ettrich, Thomas J., Hann, Alexander, Schmidt, Stefan A., Kleger, Alexander, Marienfeld, Ralf, Seufferlein, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788622/ https://www.ncbi.nlm.nih.gov/pubmed/29416754 http://dx.doi.org/10.18632/oncotarget.23330

Ejemplares similares

Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA
por: Berger, Andreas W., et al.
Publicado: (2017)

Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
por: Ettrich, T. J., et al.
Publicado: (2019)

Systemic Therapy for Metastatic Pancreatic Cancer
por: Ettrich, Thomas J., et al.
Publicado: (2021)

A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer
por: Berger, Andreas W., et al.
Publicado: (2019)

DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
por: Perkhofer, Lukas, et al.
Publicado: (2021)

Comparative Panel Sequencing of DNA Variants in cf-, ev- and tumorDNA for Pancreatic Ductal Adenocarcinoma Patients
por: Waldenmaier, Mareike, et al.
Publicado: (2022)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
por: Melzer, Michael Karl, et al.
Publicado: (2020)

The Impact of Bioactive Lipids on Cardiovascular Development
por: Kleger, Alexander, et al.
Publicado: (2011)

Differentiation of human pluripotent stem cells into pancreatic duct-like organoids
por: Breunig, Markus, et al.
Publicado: (2021)

A Systematic Comparative Study on the Diagnostic Value of Transabdominal Ultrasound in Patients with Pancreatic Cystic Lesions
por: Hentschel, Viktoria, et al.
Publicado: (2022)

Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy
por: Roger, Elodie, et al.
Publicado: (2020)

Microbial Spectra and Clinical Outcomes from Endoscopically Drained Pancreatic Fluid Collections: A Descriptive Cohort Study
por: Hentschel, Viktoria, et al.
Publicado: (2022)

Pluripotency Factors on Their Lineage Move
por: Weidgang, Clair E., et al.
Publicado: (2016)

A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response
por: Beutel, Alica K., et al.
Publicado: (2021)

Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks
por: Perkhofer, Lukas, et al.
Publicado: (2019)

Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection-Therapy: A Retrospective Study
por: Müller, Martin, et al.
Publicado: (2015)

Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Enteropathogenic Infections: Organoids Go Bacterial
por: Hentschel, Viktoria, et al.
Publicado: (2021)

Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients
por: Park, Gahee, et al.
Publicado: (2018)

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
por: Ettrich, Thomas J., et al.
Publicado: (2018)

IFN-γ treatment protocol for MHC-I(lo)/PD-L1(+) pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential
por: Stifter, Katja, et al.
Publicado: (2020)

Precision medicine meets the DNA damage response in pancreatic cancer
por: Perkhofer, Lukas, et al.
Publicado: (2018)

Single-cell profiling of GP2-enriched pancreatic progenitors to simultaneously create acinar, ductal, and endocrine organoids
por: Merz, Sarah, et al.
Publicado: (2023)

Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2018)

Definitive Endoderm Formation from Plucked Human Hair-Derived Induced Pluripotent Stem Cells and SK Channel Regulation
por: Illing, Anett, et al.
Publicado: (2013)

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma
por: Ettrich, Thomas J., et al.
Publicado: (2016)

Functional Genomic Screening in Human Pluripotent Stem Cells Reveals New Roadblocks in Early Pancreatic Endoderm Formation
por: Krüger, Jana, et al.
Publicado: (2022)

Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma
por: Diefenbach, Russell J., et al.
Publicado: (2019)

Rescue of Non-Informative Circulating Tumor DNA to Monitor the Mutational Landscape in NSCLC
por: Mayer, Stefanie, et al.
Publicado: (2020)

Transcriptional changes and the role of ONECUT1 in hPSC pancreatic differentiation
por: Heller, Sandra, et al.
Publicado: (2021)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab
por: Backhus, Johanna, et al.
Publicado: (2021)

Protocol for MInimizing the Risk of Metachronous Adenomas of the CoLorectum with Green Tea Extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population
por: Stingl, Julia C, et al.
Publicado: (2011)

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
por: Krug, Sebastian, et al.
Publicado: (2021)

The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy
por: Sturm, Niklas, et al.
Publicado: (2022)

TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regeneration
por: Melzer, Michael Karl, et al.
Publicado: (2023)

Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients
por: Muendlein, Axel, et al.
Publicado: (2021)

A time frame permissive for Protein Kinase D2 activity to direct angiogenesis in mouse embryonic stem cells
por: Müller, Martin, et al.
Publicado: (2015)

Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe
por: Taieb, Julien, et al.
Publicado: (2023)

Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer
por: Gout, Johann, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7473tk8v1ea3bu75ncs1n3eqb2